All Government articles – Page 29
-
NewsMassachusetts crime lab scandal could widen as another chemist is investigated
A third Massachusetts state chemist is being investigated for possible misconduct that might have resulted in wrongful convictions
-
BusinessChaos on Capitol Hill prompts changes in pharma and biotech
Dow won’t donate to lawmakers who refused to certify presidential votes, others like 3M, Amgen, BIO and PhRMA pause political giving to reassess
-
NewsGovernment to review gene-editing regulations for animals and crops in England
Consultation seeks public’s view on genetically-modified organisms produced using tools such as Crispr
-
OpinionClimate action plans will point to methane metrics in 2021
It’s good to see policymakers and companies making methane emissions data a priority
-
BusinessChemicals industry roundup 2020
Pandemic provides impetus to re-tune supply chains for resilience and sustainability
-
BusinessPharmaceuticals roundup 2020
Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum
-
NewsMystery illness that hospitalised hundreds in India stumps health experts
Authorities are looking at pesticide contamination of food and water as well as heavy metals
-
ResearchExplainer: How would UK science be affected by a no-deal Brexit?
Access to EU science schemes, freedom of movement and student places are all expected to be disrupted
-
BusinessCybercriminals target Covid-19 vaccines
Officials in the UK and US warn of threat from cyber-attacks that steal data related to Covid-19 vaccines and aim to disrupt the supply chain
-
NewsEU budget agreement boosts European Research Council with extra €1.1bn
Researchers bemoan static funding in EU science programmes as final budget details hammered out
-
BusinessPfizer–BioNTech vaccine gains emergency approvals in US, Canada and beyond
UK begins vaccinating vulnerable populations after early authorisation
-
BusinessUK grants Pfizer–BioNTech Covid-19 vaccine emergency approval
Regulators around the world working towards accelerated decisions on vaccine data
-
BusinessBrexit may put some chemicals out of GB’s Reach
Industry fears divergence of UK and EU regulations could spell disaster for trade
-
NewsResearchers welcome government’s £15bn commitment to ‘turn the UK into scientific superpower’
Spending review promise puts country on track to invest 2.4% of GDP in research and development by 2027
-
-
NewsUK government faces lawsuit over procurement of Covid immunity test
The health department reportedly knew that the antibody test did not perform as well as claimed when it bought them
-
NewsEuropeans want nanomaterial products to be labelled, survey shows
While awareness of nanomaterials in everyday products remains low, 87% of people want them noted, surveys in five European countries shows
-
BusinessRegulatory panel unconvinced by Alzheimer’s antibody evidence
US FDA advisors vote against approving Biogen’s aducanumab on the basis of incomplete data analysis
-
NewsScientists urge caution on use of lateral flow tests to screen for Covid-19
Preliminary review reveals devices perform poorly at identifying people infected with Sars-CoV-2
-
NewsScientists dismayed by underfunded and underpowered EU research programme
Funding matches that earmarked for science and R&D seven years ago